• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过包合络合和固体分散技术改善拉莫三嗪的溶出特性。

Improvement of dissolution properties of lamotrigine by inclusion complexation and solid dispersion technique.

作者信息

Parmar Komal R, Satapara Vijay P, Shah Sunny R, Sheth Navin R

机构信息

Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India.

出版信息

Pharmazie. 2011 Feb;66(2):119-23.

PMID:21434574
Abstract

The aim of the present work was to improve the dissolution characteristics of the poorly water soluble antiepileptic drug lamotrigine (LMN) by inclusion complexation using hydroxy propyl beta-cyclodextrin (HP beta-CD) by co-evaporation technique and by, solid dispersion, prepared by the melt method using poloxamer 407 (L 127). Phase solubility studies showed AL type curves with both the carriers. Dissolution of LMN was significantly improved (p < 0.05) by inclusion complexation and solid dispersion preparation. Results of solid state characterization performed by Fourier Transform Infrared Spectroscopy, Differential Scanning Calorimetry and Powder X-ray Diffractrometry techniques revealed a decrease in the crystallinity of LMN that might be accounting for improvement in the dissolution properties as seen from dissolution studies.

摘要

本研究的目的是通过共蒸发技术使用羟丙基-β-环糊精(HPβ-CD)以及通过采用泊洛沙姆407(L127)的熔融法制备固体分散体,通过包合络合来改善难溶性抗癫痫药物拉莫三嗪(LMN)的溶出特性。相溶解度研究表明两种载体均呈现AL型曲线。通过包合络合和固体分散体制备,LMN的溶出度得到显著提高(p<0.05)。通过傅里叶变换红外光谱、差示扫描量热法和粉末X射线衍射技术进行的固态表征结果显示,LMN的结晶度降低,这可能是从溶出度研究中观察到的溶出性能改善的原因。

相似文献

1
Improvement of dissolution properties of lamotrigine by inclusion complexation and solid dispersion technique.通过包合络合和固体分散技术改善拉莫三嗪的溶出特性。
Pharmazie. 2011 Feb;66(2):119-23.
2
Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.通过包合络合和固体分散技术提高拉莫三嗪的溶解度和溶出速率。
J Pharm Pharmacol. 2008 Sep;60(9):1121-9. doi: 10.1211/jpp.60.9.0002.
3
Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.采用超临界抗溶剂(SAS)法制备辛伐他汀/羟丙基-β-环糊精包合物及其表征
Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. doi: 10.1016/j.ejpb.2006.11.013. Epub 2006 Nov 29.
4
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
5
Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.丹参酮 IIA 固体分散体的制备及理化性质研究。
Arch Pharm Res. 2011 Jun;34(6):949-59. doi: 10.1007/s12272-011-0612-3. Epub 2011 Jul 2.
6
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.盐酸布比卡因环糊精包合物的制备及其口腔给药的固态特性研究。
J Pharm Biomed Anal. 2010 May 1;52(1):9-18. doi: 10.1016/j.jpba.2009.11.013. Epub 2009 Nov 18.
7
Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.固体分散体法对他克莫司溶解度和结晶性质的影响。
Int J Pharm. 2010 Aug 16;395(1-2):161-6. doi: 10.1016/j.ijpharm.2010.05.023. Epub 2010 May 24.
8
Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.环糊精与磷脂的络合作用对溶解度和溶出度的提高:一项批判性和荟萃分析。
Expert Opin Drug Deliv. 2014 Aug;11(8):1255-72. doi: 10.1517/17425247.2014.916271. Epub 2014 Jun 7.
9
Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.采用溶剂蒸发法制备的三种抗癫痫药物固体分散体的物理化学表征
J Pharm Pharmacol. 2007 May;59(5):645-53. doi: 10.1211/jpp.59.5.0004.
10
Preparation, characterization and tableting of cilnidipine solid dispersions.西尼地平固体分散体的制备、表征及压片
Pak J Pharm Sci. 2013 May;26(3):629-36.

引用本文的文献

1
In vitro and in vivo evaluation of fast-dissolving tablets containing solid dispersion of lamotrigine.含有拉莫三嗪固体分散体的速溶片的体外和体内评价
Int J Pharm Investig. 2015 Jan-Mar;5(1):57-64. doi: 10.4103/2230-973X.147235.
2
Novel patchouli alcohol ternary solid dispersion pellets prepared by poloxamers.泊洛沙姆制备的新型广藿香醇三元固体分散体微丸
Iran J Pharm Res. 2015 Winter;14(1):15-26.
3
Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.丹参酮 IIA 固体分散体与硅纳米粒子的制备、表征及体内评价。
Int J Nanomedicine. 2013;8:2285-93. doi: 10.2147/IJN.S40374. Epub 2013 Jun 25.
4
Preparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: in vivo and in vitro evaluations.纳米尺度宝藿苷 I-磷脂复合物的制备及其吸收的体内外评价。
Int J Nanomedicine. 2012;7:4907-16. doi: 10.2147/IJN.S35965. Epub 2012 Sep 13.